These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 2114832)

  • 1. A possible mechanism of action for azelaic acid in the human epidermis.
    Schallreuter KU; Wood JW
    Arch Dermatol Res; 1990; 282(3):168-71. PubMed ID: 2114832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azelaic acid as a competitive inhibitor of thioredoxin reductase in human melanoma cells.
    Schallreuter KU; Wood JM
    Cancer Lett; 1987 Sep; 36(3):297-305. PubMed ID: 3652030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of azelaic acid on cultures of lymphoma- and leukemia-derived cell lines, normal resting and stimulated lymphocytes and 3T3 fibroblasts.
    Picardo M; Passi S; Sirianni MC; Fiorilli M; Russo GD; Cortesi E; Barile G; Breathnach AS; Nazzaro-Porro M
    Biochem Pharmacol; 1985 May; 34(10):1653-8. PubMed ID: 4004885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azelaic acid. A review of its pharmacological properties and therapeutic efficacy in acne and hyperpigmentary skin disorders.
    Fitton A; Goa KL
    Drugs; 1991 May; 41(5):780-98. PubMed ID: 1712709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azelaic acid-loaded nanoemulsion with hyaluronic acid - a new strategy to treat hyperpigmentary skin disorders.
    Jacobus Berlitz S; De Villa D; Maschmann Inácio LA; Davies S; Zatta KC; Guterres SS; Külkamp-Guerreiro IC
    Drug Dev Ind Pharm; 2019 Apr; 45(4):642-650. PubMed ID: 30642209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of thioredoxin reductase in the reduction of free radicals at the surface of the epidermis.
    Schallreuter KU; Wood JM
    Biochem Biophys Res Commun; 1986 Apr; 136(2):630-7. PubMed ID: 2423087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanin hyperpigmentation of skin: melasma, topical treatment with azelaic acid, and other therapies.
    Breathnach AS
    Cutis; 1996 Jan; 57(1 Suppl):36-45. PubMed ID: 8654129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of azelaic acid on neutrophil functions: a possible cause for its efficacy in treating pathogenetically unrelated diseases.
    Akamatsu H; Komura J; Asada Y; Miyachi Y; Niwa Y
    Arch Dermatol Res; 1991; 283(3):162-6. PubMed ID: 1867478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dicarboxylic acids on lentigo maligna.
    Nazzaro-Porro M; Passi S; Balus L; Breathnach A; Martin B; Morpurgo G
    J Invest Dermatol; 1979 Jun; 72(6):296-305. PubMed ID: 448162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dicarboxylic acids on normal human melanocytes in dispersed tissue culture.
    Breathnach AS; Martin B; Nazzaro Porro M; Passi S; Mann P; Cooper J; Morpurgo G
    Br J Dermatol; 1979 Dec; 101(6):641-9. PubMed ID: 534609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of DNA synthesis of melanoma cells by azelaic acid.
    Leibl H; Stingl G; Pehamberger H; Korschan H; Konrad K; Wolff K
    J Invest Dermatol; 1985 Nov; 85(5):417-22. PubMed ID: 4056455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanism of azelaic acid action in acne].
    Passi S; Picardo M; De Luca C; Nazzaro-Porro M
    G Ital Dermatol Venereol; 1989 Oct; 124(10):455-63. PubMed ID: 2534550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into the anti-inflammatory and anti-melanoma mechanisms of action of azelaic acid and other Fusarium solani metabolites via in vitro and in silico studies.
    Ismail M; Hassan MHA; Mohamed EIA; Azmy AF; Moawad A; Mohammed R; Zaki MA
    Sci Rep; 2024 Jun; 14(1):14370. PubMed ID: 38909081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azelaic acid.
    Nazzaro-Porro M
    J Am Acad Dermatol; 1987 Dec; 17(6):1033-41. PubMed ID: 2963038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of azelaic acid on proliferation and ultrastructure of mouse keratinocytes in vitro.
    Detmar M; Mayer-da-Silva A; Stadler R; Orfanos CE
    J Invest Dermatol; 1989 Jul; 93(1):70-4. PubMed ID: 2473140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the combination of different depigmenting agents in vitro.
    Martínez-Gutiérrez A; Asensio JA; Aran B
    J Cosmet Sci; 2014; 65(6):365-75. PubMed ID: 25898763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in-vitro antimicrobial effects of azelaic acid upon Propionibacterium acnes strain P37.
    Bojar RA; Holland KT; Cunliffe WJ
    J Antimicrob Chemother; 1991 Dec; 28(6):843-53. PubMed ID: 1726169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azelaic acid--biochemistry and metabolism.
    Passi S; Picardo M; Mingrone G; Breathnach AS; Nazzaro-Porro M
    Acta Derm Venereol Suppl (Stockh); 1989; 143():8-13. PubMed ID: 2505463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell cycle inhibition of HTLV-I transformed T cell lines by retinoic acid: the possible therapeutic use of thioredoxin reductase inhibitors.
    U-Taniguchi Y; Furuke K; Masutani H; Nakamura H; Yodoi J
    Oncol Res; 1995; 7(3-4):183-9. PubMed ID: 8555652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of 5 alpha-reductase activity in human skin by zinc and azelaic acid.
    Stamatiadis D; Bulteau-Portois MC; Mowszowicz I
    Br J Dermatol; 1988 Nov; 119(5):627-32. PubMed ID: 3207614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.